MetLife Investment Management’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $155K | Sell |
7,263
-47,428
| -87% | -$1.01M | ﹤0.01% | 2316 |
|
|
2025
Q1 | $1.05M | Sell |
54,691
-715
| -1% | -$13.8K | 0.01% | 1338 |
|
|
2024
Q4 | $989K | Buy |
55,406
+3,981
| +8% | +$71K | 0.01% | 1420 |
|
|
2024
Q3 | $1.13M | Hold |
51,425
| – | – | 0.01% | 1331 |
|
|
2024
Q2 | $401K | Sell |
51,425
-11,893
| -19% | -$92.8K | ﹤0.01% | 1846 |
|
|
2024
Q1 | $262K | Hold |
63,318
| – | – | ﹤0.01% | 2044 |
|
|
2023
Q4 | $165K | Hold |
63,318
| – | – | ﹤0.01% | 2344 |
|
|
2023
Q3 | $118K | Hold |
63,318
| – | – | ﹤0.01% | 2494 |
|
|
2023
Q2 | $159K | Buy |
+63,318
| New | +$159K | ﹤0.01% | 2407 |
|